Metropolis launches GLP-1 monitoring test packages, targets obesity market
Metropolis Healthcare has rolled out three TruHealth GLP-1 test packages for patients preparing for or undergoing obesity treatment, as diagnostics firms move to tap the fast-growing segment
UPSC Key: Sanchar Saathi app, GPS ‘spoofing’, and WHO guidelines on use of GLP-1
Post Content
Overlooked hormone may be deadly driver of postmenopausal breast cancer in women with obesity
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in postmenopausal women with obesity. It also raises the possibility that treatment of these aggressive breast cancers could be improved with the addition […]
WHO issues first guidelines backing GLP-1 drugs for obesity management
WHO has issued its first guidelines recommending GLP-1 drugs for long-term obesity treatment in adults, while stressing equitable access, health system readiness and lifestyle support
Drug Combo Tied to Lower Cancer Risk, Mortality in T2D
Dual therapy with metformin and GLP-1 RAs is associated with a lower risk for adiposity-related cancers and mortality than DPP-4 inhibitor therapy in patients with T2D. Medscape Medical News
What are GLP-1 therapies?
GLP-1 therapies are a class of medicines that help lower blood sugar, support weight loss, reduce the risk of heart and kidney complications, and can even lower the risk of early death in people with type 2 diabetes. These must be prescribed by your health care specialist and require close follow-ups. People living with obesity, […]
Expanded Medicare Coverage Could Bring GLP-1s to Millions
The federal government negotiated with drug makers to bring lower prices on GLP-1 drugs to millions of Medicare patients. Medscape Medical News
FTSE 100 vs S&P 500: here’s how £10k invested at the start of the year compares
It’s been a volatile year in stock markets around the world. From tariff scares through to monetary policy shifts, investors have been left trying to dodge market corrections and carefully navigate which stocks to buy and which to avoid. But if an investor had decided to park £10k in a tracker fund of either the […]
Eli Lilly reduces Zepbound price
Eli Lilly has lowered the price of its GLP-1 drug Zepbound (tirzepatide) in single-dose vials, with the starting dose now available for $299 per month through the company’s direct-to-consumer platform, LillyDirect. The drugmaker said in a Dec. 1 news release the price cut is part of a broader effort to reduce out-of-pocket costs and expand […]
Warning over weight loss jab shortage as obesity set to double by 2030
GLP-1 medication, such as Wegovy, was added to the list of ‘essential’ medicines by the World Health Organization in September